1994
DOI: 10.1128/aac.38.7.1647
|View full text |Cite
|
Sign up to set email alerts
|

Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda

Abstract: The in vitro susceptibilities of 112 clinical isolates of Haemophilus ducreyi to six antimicrobial agents were determined. These isolates were obtained in Kigali, Rwanda

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1995
1995
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 11 publications
(2 reference statements)
0
4
0
Order By: Relevance
“…One strain with a ciprofloxacin MIC of 2.0 g/ml has been isolated in Thailand (75); however, quinolone resistance does not appear to be widespread. H. ducreyi resistance to TMP-SMX has been reported in Rwanda (166); the prevalence of resistant strains increased from 9% (2 of 23) in 1988 to 48% (34 of 71) of strains examined in 1991. All of the TMP-SMXresistant isolates were resistant to TMP (MIC, Ͼ4.0 g/ml).…”
Section: Treatmentmentioning
confidence: 97%
“…One strain with a ciprofloxacin MIC of 2.0 g/ml has been isolated in Thailand (75); however, quinolone resistance does not appear to be widespread. H. ducreyi resistance to TMP-SMX has been reported in Rwanda (166); the prevalence of resistant strains increased from 9% (2 of 23) in 1988 to 48% (34 of 71) of strains examined in 1991. All of the TMP-SMXresistant isolates were resistant to TMP (MIC, Ͼ4.0 g/ml).…”
Section: Treatmentmentioning
confidence: 97%
“…Our clinicians did suspect chancroid in a few cases, but the service program did not record detailed descriptions or photographs of ulcers and we lacked laboratory diagnostics. The most recent [55][56][57][58][59]. For many years the prevalence of HD had been decreasing in much of Africa [48,54], but recent publications indicate HD may be staging a comeback [21].…”
Section: Plos Onementioning
confidence: 99%
“…50 There is little, if any, antimicrobial surveillance occurring in countries where chancroid is common. Based on the emergence of resistant strains in Rwanda, 51 the WHO has recommended that chancroid is not treated with trimethoprim/sulfamethoxazole based regimens unless the antimicrobial susceptibility profiles of local H ducreyi isolates are known. 42 Fluctuant buboes should be aspirated in order to provide symptomatic relief for the patient and to avoid the further complication of spontaneous rupture.…”
Section: Treatmentmentioning
confidence: 99%